HERNANDEZ CANO, Rosa Mª; LORENZO HERNANDEZ, Mª Piedad    SORIA SUAREZ, Mª Isabel. Use of zoledronic acid in the treatment of multiple myeloma. []. , 12, 32, pp.51-61. ISSN 1695-6141.

The main objective of the case was whether the use of bisphosphonates in the treatment of multiple myeloma is effective for decreasing pain in patient and to evaluate the reduction of hypercalcemia or not. We have studied a case of a patient undergoing chemotherapy and treated with Zometa^® in the Regional Hospital of Baza (Granada-Spain), during the first session of treatment the patient revealed favourable results as evidenced decreased incidence of hypercalcemia and pain reduction. After an exhaustive assessment of the patient, three nursing diagnoses were selected; the most appropriate interventions for each of these diagnoses were planned, using NANDA taxonomy, NIC and NOC taxonomy. During treatment the patient had some variation in body temperature and insignificant nausea in the first sessions, as well as decreased pain which led to use less analgesics, normalization of serum calcium levels and an increase in her quality of life. The findings of the study identified a positive effect on the administration of Zoledronic Acid as the expected results were obtained and the side effects were minimal, without interrupting the treatment.

: Bisphosphonates; Multiple Myeloma; Zoledronic Acid; Bone Methastasis; Bone Pain.

        · |     · |     · ( pdf )